Journal of Oncology / 2012 / Article / Tab 2

Review Article

Tumor Angiogenesis as a Target for Dietary Cancer Prevention

Table 2

Endogenous inhibitors of angiogenesis.

Angiopoietin-2 (in the absence of VEGF)
Angiostatin
Antithrombin III fragment
Arresten
Canstatin
Chondromodulin I
Connective tissue growth factor (CTGF)
Decorin
Endorepellin
Endostatin
Fibronectin 20-kDa fragment
Interferons-α, β, and γ
Interleukin-4 (IL-4)
Interleukin-10 (IL-10)
Interleukin-12 (IL-12)
Interferon-inducible protein-10 (IP-10)
Kringle 5
Metastatin
METH-1
METH-2
2-Methoxyestradiol
Osteopontin cleavage product
PEX
Pigment epithelium-derived factor (PEDF)
Plasminogen activator inhibitor (PAI)
Platelet factor-4
Prolactin 16-KDa fragment
Proliferin-related protein
Prothrombin kringle 2
Maspin
Restin
Soluble fms-like tyrosine kinase-1 (S-Flt-1)
SPARC cleavage product
Tetrahydrocortisol-S
Tissue inhibitors of matrix metalloproteinases (TIMPs)
Thrombospondin-1 and -2
Transforming growth factor-β (TGF-β) (activated form)
Troponin-1
Tumstatin
Vascular endothelial growth inhibitor (VEGI)
Vasostatin

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.